1. Home
  2. IMAB vs FAT Comparison

IMAB vs FAT Comparison

Compare IMAB & FAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • FAT
  • Stock Information
  • Founded
  • IMAB 2014
  • FAT 2017
  • Country
  • IMAB United States
  • FAT United States
  • Employees
  • IMAB N/A
  • FAT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • FAT Restaurants
  • Sector
  • IMAB Health Care
  • FAT Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • FAT Nasdaq
  • Market Cap
  • IMAB 79.9M
  • FAT 94.4M
  • IPO Year
  • IMAB 2020
  • FAT 2017
  • Fundamental
  • Price
  • IMAB $0.97
  • FAT $3.50
  • Analyst Decision
  • IMAB Strong Buy
  • FAT
  • Analyst Count
  • IMAB 3
  • FAT 0
  • Target Price
  • IMAB $8.00
  • FAT N/A
  • AVG Volume (30 Days)
  • IMAB 270.1K
  • FAT 123.1K
  • Earning Date
  • IMAB 03-13-2025
  • FAT 03-06-2025
  • Dividend Yield
  • IMAB N/A
  • FAT 16.00%
  • EPS Growth
  • IMAB N/A
  • FAT N/A
  • EPS
  • IMAB N/A
  • FAT N/A
  • Revenue
  • IMAB $569,464.00
  • FAT $606,008,000.00
  • Revenue This Year
  • IMAB N/A
  • FAT $27.15
  • Revenue Next Year
  • IMAB N/A
  • FAT $10.38
  • P/E Ratio
  • IMAB N/A
  • FAT N/A
  • Revenue Growth
  • IMAB N/A
  • FAT 42.38
  • 52 Week Low
  • IMAB $0.84
  • FAT $2.51
  • 52 Week High
  • IMAB $2.00
  • FAT $5.09
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 46.51
  • FAT 48.72
  • Support Level
  • IMAB $0.96
  • FAT $3.61
  • Resistance Level
  • IMAB $1.04
  • FAT $3.89
  • Average True Range (ATR)
  • IMAB 0.05
  • FAT 0.23
  • MACD
  • IMAB -0.00
  • FAT -0.04
  • Stochastic Oscillator
  • IMAB 36.36
  • FAT 6.26

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About FAT FAT Brands Inc.

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.

Share on Social Networks: